PACB - Pacific Biosciences of California, Inc.
| Previous Close | 4.50 |
| Open | 4.50 |
| Bid | 4.54 x 3300 |
| Ask | 4.55 x 600 |
| Day's Range | 4.50 - 4.75 |
| 52 Week Range | 3.08 - 9.07 |
| Volume | 592,955 |
| Avg. Volume | 991,750 |
| Market Cap | 524.78M |
| Beta | 2.93 |
| PE Ratio (TTM) | -4.96 |
| EPS (TTM) | -0.92 |
| Earnings Date | Oct 31, 2017 - Nov 6, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.28 |
- Capital Cube•yesterday
ETFs with exposure to Pacific Biosciences of California, Inc. : October 17, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pacific Biosciences of California, Inc. Here are 5 ETFs with the largest exposure to PACB-US. Comparing the performance and risk of Pacific Biosciences of California, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)
- GlobeNewswire•2 days ago
Recent Projects Highlight Success of SMRT Sequencing for Characterizing Structural Variation in Human Genomes
MENLO PARK, Calif., Oct. 16, 2017-- A series of publications and initiatives from the genomics community demonstrates the rapid adoption of Single Molecule, Real-Time Sequencing for discovering structural ...
Capital Cube•7 days agoPacific Biosciences of California, Inc. breached its 50 day moving average in a Bearish Manner : PACB-US : October 11, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Pacific Biosciences of California, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)
- Zacks•8 days ago
Pacific Biosciences, Bluebee Team Up for De Novo Sequencing
With increasing demand for SMRT sequencing in the genomics community, both Pacific Biosciences (PACB) and partner Bluebee expect a huge customer adoption of integrated de novo assembly pipeline.
- PR Newswire•9 days ago
PacBio and Bluebee Launch De Novo Genome Assembly Pipeline on the Bluebee Analysis Platform
RIJSWIJK, The Netherlands and MENLO PARK, Calif , October 9, 2017 /PRNewswire/ -- Bluebee, a company driving genomic data-driven medicine, and Pacific Biosciences of California , Inc. (NASDAQ:PACB), the ...
- Capital Cube•13 days ago
ETFs with exposure to Pacific Biosciences of California, Inc. : October 5, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pacific Biosciences of California, Inc. Here are 5 ETFs with the largest exposure to PACB-US. Comparing the performance and risk of Pacific Biosciences of California, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)
Capital Cube•14 days agoPacific Biosciences of California, Inc. :PACB-US: Earnings Analysis: Q2, 2017 By the Numbers : October 4, 2017
Categories: Yahoo FinanceGet free summary analysis Pacific Biosciences of California, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 20.07 million, Net Earnings of USD -25.54 million. Gross margins narrowed from 51.30% to 39.86% compared to the same period last year, operating (EBITDA) margins now -111.58% from -82.40%. Change ... Read more (Read more...)
- GlobeNewswire•15 days ago
Structural Variation Detection a Key Focus of PacBio Sequencing Projects Presented at ASHG Annual Meeting
MENLO PARK, Calif., Oct. 03, 2017-- Pacific Biosciences of California, Inc., today announced that the human genetics community is demonstrating increasing recognition of the value of Single Molecule, Real-Time ...
- Motley Fool•last month
Why Illumina Rose 18.7% in August
The market cheered blowout quarterly results.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of PACB earnings conference call or presentation 2-Aug-17 8:30pm GMT
Q2 2017 Pacific Biosciences of California Inc Earnings Call
- Motley Fool•2 months ago
What's Behind Pacific Biosciences of California's Stock Rally Today?
Shares of the high-accuracy genomic sequencing company continue to rise despite a lack of significant news.
Zacks•2 months agoPacific Biosciences (PACB) Posts Wider-than-Expected Q2 Loss
Pacific Biosciences (PACB) posted a dull quarter with revenues declining in Q2. However, the company continues to anticipate 35% to 45% growth in product and service revenues for the year.
Capital Cube•2 months agoPacific Biosciences of California, Inc. breached its 50 day moving average in a Bullish Manner : PACB-US : August 4, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Pacific Biosciences of California, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)
- Capital Cube•2 months ago
Pacific Biosciences of California, Inc. – Value Analysis (NASDAQ:PACB) : August 4, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Pacific Biosciences of California, Inc. a score of 16. Our analysis is based on comparing Pacific Biosciences of California, Inc. with the following peers – Illumina, Inc., NanoString Technologies, Inc., Thermo Fisher Scientific Inc., PerkinElmer, Inc., Fluidigm Corporation, Luminex Corp and General Electric Company (ILMN-US, NSTG-US, TMO-US, ... Read more (Read more...)
- Motley Fool•2 months ago
Here's Why Pacific Biosciences of California Is Surging Today
The sequencing company topped off a solid second-quarter earnings report with news of a big order from its best customer.
- Motley Fool•2 months ago
Pacific Biosciences of California Struggles in the Second Quarter With Lower Sales
The genetic-sequencing company's lone bright spot was higher product sales, but it wasn't enough to offset the loss of contract revenue.
- Associated Press•3 months ago
Pacific Biosciences reports 2Q loss
On a per-share basis, the Menlo Park, California-based company said it had a loss of 26 cents. The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks ...
- GlobeNewswire•3 months ago
Pacific Biosciences of California, Inc. Announces Second Quarter 2017 Financial Results
MENLO PARK, Calif., Aug. 02, 2017-- Pacific Biosciences of California, Inc. today announced financial results for its second quarter ended June 30, 2017.. Product, service and other revenue for the second ...
- GlobeNewswire•3 months ago
PacBio Announces New Agreement with Novogene to Purchase Ten Sequel Systems
MENLO PARK, Calif. and SAN DIEGO, Aug. 02, 2017-- Pacific Biosciences of California, Inc. and Novogene Corporation today announced a new agreement by Novogene to purchase 10 Sequel ® Systems, giving the ...
- ACCESSWIRE•3 months ago
Investor Network: Pacific Biosciences of California, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 2, 2017 / Pacific Biosciences of California, Inc. (NASDAQ: PACB ) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August ...
- GlobeNewswire•3 months ago
Pacific Biosciences of California, Inc. Second Quarter 2017 Financial Results Call
MENLO PARK, Calif., July 24, 2017-- Pacific Biosciences of California, Inc. will hold its quarterly conference call to discuss its Second Quarter 2017 Financial Results on Wednesday, August 2, 2017, at ...
Capital Cube•3 months agoPacific Biosciences of California, Inc. breached its 50 day moving average in a Bearish Manner : PACB-US : July 20, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Pacific Biosciences of California, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)
- Capital Cube•3 months ago
ETFs with exposure to Pacific Biosciences of California, Inc. : July 5, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pacific Biosciences of California, Inc. Here are 5 ETFs with the largest exposure to PACB-US. Comparing the performance and risk of Pacific Biosciences of California, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)
